Paper27273168
The role of the gut microbiota in NAFLD.
Leung C and 3 others. Nat Rev Gastroenterol Hepatol, 2016. Cited by 829 papers, by iCite.
Cite this record
ConductScience Library. The role of the gut microbiota in NAFLD. Papers, record 27273168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27273168
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Bile Acids and Salts | |
| Diet | |
| Disease Progression | |
| Ethanol | |
| Exercise | |
| Fatty Acids, Volatile | |
| Fungi | |
| Gastrointestinal Motility | |
| Glucose | |
| Gram-Negative Bacteria | |
| Gram-Positive Bacteria | |
| Host-Pathogen Interactions | |
| Humans | |
| Intestines | |
| Liver | |
| Methylamines | |
| Permeability | |
| Phosphatidylcholines | |
| Prebiotics | |
| Probiotics | |
| Receptors, G-Protein-Coupled | |
| Sleep | |
| Viruses |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04671186 | Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan | Background | ClinicalTrials.gov | |
| NCT06682663 | Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women | Background | ClinicalTrials.gov | |
| NCT07857941 | Exploring Novel Therapeutic Approaches for Disorders of Gut-Liver-Brain Interaction-H1/H2 | Background | ClinicalTrials.gov |
References187
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24372861 | Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. | J Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/24372861 | PubMed |
| 2 | 15640457 | Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. | Am J Clin Nutr | 2005 | https://conductscience.org/library/papers/15640457 | PubMed |
| 3 | 24226770 | Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. | Nature | 2013 | https://conductscience.org/library/papers/24226770 | PubMed |
| 4 | 25957914 | Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. | Int J Biochem Cell Biol | 2015 | https://conductscience.org/library/papers/25957914 | PubMed |
| 5 | 24508599 | Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24508599 | PubMed |
| 6 | 23551139 | Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. | FEMS Microbiol Lett | 2013 | https://conductscience.org/library/papers/23551139 | PubMed |
| 7 | 25564811 | Overstated associations between fructose and nonalcoholic fatty liver disease. | J Pediatr Gastroenterol Nutr | 2015 | https://conductscience.org/library/papers/25564811 | PubMed |
| 8 | 19645728 | Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. | Alcohol Clin Exp Res | 2009 | https://conductscience.org/library/papers/19645728 | PubMed |
| 9 | 23850261 | Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. | Trends Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23850261 | PubMed |
| 10 | 16895997 | Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16895997 | PubMed |
| 11 | 12604787 | Origin and evolution of circadian clock genes in prokaryotes. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12604787 | PubMed |
| 12 | 23727264 | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23727264 | PubMed |
| 13 | 22686435 | Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. | Obes Rev | 2012 | https://conductscience.org/library/papers/22686435 | PubMed |
| 14 | 18762021 | Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. | Cell Metab | 2008 | https://conductscience.org/library/papers/18762021 | PubMed |
| 15 | 25326801 | Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. | Nat Med | 2014 | https://conductscience.org/library/papers/25326801 | PubMed |
| 16 | 23396737 | Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. | Ann Hepatol | 2013 | https://conductscience.org/library/papers/23396737 | PubMed |
| 17 | 25466902 | Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. | FASEB J | 2015 | https://conductscience.org/library/papers/25466902 | PubMed |
| 18 | 10222383 | Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. | J Nutr | 1999 | https://conductscience.org/library/papers/10222383 | PubMed |
| 19 | 25021423 | Exercise and associated dietary extremes impact on gut microbial diversity. | Gut | 2014 | https://conductscience.org/library/papers/25021423 | PubMed |
| 20 | 25625278 | Implication of gut microbiota in nonalcoholic fatty liver disease. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/25625278 | PubMed |
Cited by549
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 829 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948719 | Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42948719 | PubMed |
| 42947233 | Dietary-fibre intake, genetic factors, and the risk of nonalcoholic fatty liver disease: a prospective study in the UK Biobank. | Hum Genomics | 2026 | https://conductscience.org/library/papers/42947233 | PubMed |
| 42943735 | Oleanolic Acid-Loaded Cyclodextrin Metal-Organic Framework Ameliorates NAFLD via Modulation of Gut Microbiota and Liver Metabolism. | Molecules | 2026 | https://conductscience.org/library/papers/42943735 | PubMed |
| 42939828 | Gut Microbiota-Host Redox Crosstalk: Molecular Mechanisms, Disease Pathogenesis, and Therapeutic Interventions. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939828 | PubMed |
| 42895196 | Acute liver injury is triggered by dysbiosis and microbial translocation involving gut-liver axis. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42895196 | PubMed |
| 42666665 | Mapping GLP-1 receptor agonist research across the MASLD-MASH-HCC continuum: a bibliometric and translational analysis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42666665 | PubMed |
| 42662117 | Gut microbiota and the gut-liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42662117 | PubMed |
| 42646322 | Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites. | Metabolites | 2026 | https://conductscience.org/library/papers/42646322 | PubMed |
| 42596894 | Associations between physical activity and dietary live microbe intake with non-alcoholic fatty liver disease: findings from the NHANES, 2007-2018. | J Glob Health | 2026 | https://conductscience.org/library/papers/42596894 | PubMed |
| 42588152 | The MASLD-Cardio-Oncology Triangle: Dietary Patterns, Metabolic Remodelling and Implications for Cancer Therapy Tolerance. | Nutrients | 2026 | https://conductscience.org/library/papers/42588152 | PubMed |
| 42572438 | Polyphenols as Systems Modulators of the Gut-Brain-Liver Axis: A Narrative Review of Neuro-Metabolic and Immunomodulatory Networks. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/42572438 | PubMed |
| 42528697 | Lipid-derived microbial metabolites at the gut-liver interface: regulation of intestinal barrier function, immune signaling, and metabolic inflammation. | Front Physiol | 2026 | https://conductscience.org/library/papers/42528697 | PubMed |
| 42471327 | Sheep-derived probiotics alleviate weaning-induced oxidative stress in lambs via the gut-liver axis. | NPJ Biofilms Microbiomes | 2026 | https://conductscience.org/library/papers/42471327 | PubMed |
| 42451149 | MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice. | Nutrients | 2026 | https://conductscience.org/library/papers/42451149 | PubMed |
| 42435168 | Gut-Liver Microbiome and Tumor Microenvironment in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435168 | PubMed |
| 42428317 | Herbal medicines modulate gut microbiota in metabolic diseases: a review. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42428317 | PubMed |
| 42423485 | The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies. | FASEB J | 2026 | https://conductscience.org/library/papers/42423485 | PubMed |
| 42370351 | The current status and emerging trends in the application of precision nutrition for the comprehensive, lifecycle-based management of chronic liver diseases. | Front Nutr | 2026 | https://conductscience.org/library/papers/42370351 | PubMed |
| 42351186 | Dynamic gut microbiota shift in chronic liver disease progression: machine learning models and the E/Er ratio as a predictive biomarker. | J Transl Med | 2026 | https://conductscience.org/library/papers/42351186 | PubMed |
| 42330353 | Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes. | Am J Hypertens | 2026 | https://conductscience.org/library/papers/42330353 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27273168
GET https://conductscience.org/api/papers/v1/27273168/references?page=2